Your session is about to expire
← Back to Search
Cervical Collar Device for Thyroid Disorders
Study Summary
This trial is testing a device that is worn around the neck and measures radioiodine exposure to help estimate the amount of iodine-131 that a person needs for treatment of thyroid disorders while minimizing risks of comorbidities.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have a condition affecting my neck's bones, like arthritis or wear and tear.I have a certain type of thyroid cancer needing specific treatment and can understand and follow instructions in English.I have Graves' disease confirmed by tests and I understand and can follow instructions in English.I am not pregnant, elderly, or unable to understand simple instructions.
- Group 1: Pilot Project
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are researchers still recruiting participants for this experiment?
"Affirmative. The data available on clinicaltrials.gov attests that this investigation is currently seeking applicants, having initially been published on December 11th 2018 and revised most recently as of October 5th 2022. This experiment necessitates 10 participants from a single site for enrolment."
Does the protocol for this trial encompass elderly individuals?
"This medical trial includes a lower limit of 21 years old and an upper bound at 65. Consequently, all participants must fall within this age bracket to be eligible for inclusion in the study."
What criteria must a participant meet in order to qualify for this research?
"Individuals between 21 and 65 years old with a diagnosis of Graves disease are eligible to apply for this study, which is limited to 10 participants."
What is the current size of the participant pool for this clinical investigation?
"Affirmative. As per the clinicaltrials.gov records, this clinical trial is still enrolling individuals and was first launched on December 11th 2018 with its most recent update occurring October 5th 2022. A total of 10 people are expected to join from one select medical centre."
Share this study with friends
Copy Link
Messenger